Nanospectra Biosciences Inc.

Nanospectra is a clinical-stage medical device company that is pioneering a new cancer therapy. Their technology uses gold-silica nanoshells (AuroShells(R)) that are designed to accumulate in tumors and, when illuminated with a near-infrared laser, heat up to selectively destroy the cancer cells with minimal damage to healthy tissue.